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DOI: http://dx.doi.org/10.1016/j.hemonc.2013.06.002Lymphoplasmacytic lymphoma is a chronic lymphoproliferative disorder characterized by a proliferation
of plasma cells, small lymphocytes, plasmacytoid lymphocytes and the production of monoclonal IgM.
Primary central nervous system lymphomas (PCNSL) are rare non-Hodgkin lymphomas (NHL) that can
be found in the brain, leptomeninges, eyes or spinal cord, and are mostly intracerebral. PCNSLs constitute
3–4% of primary brain tumors, and in most cases are diffuse large B-cell lymphomas (DLBCL).1 Low grade
lymphomas as primary central nervous system (CNS) lymphoma are very rare. We present here a case
report of a woman who presented with headache and was found to have primary intracranial lymphoplas-
macytic lymphoma (LPL).Lymphoplasmacytic lymphoma is a chronic lym-phoproliferative disorder characterized by pro-liferation of plasma cells, small lymphocytes,
plasmacytoid lymphocytes and the production of
monoclonal IgM. Primary central nervous system
lymphomas (PCNSL) are rare non-Hodgkin lympho-
mas (NHL) that can be found in the brain, leptome-
ninges, eyes or spinal cord, and are mostly
intracerebral. PCNSLs constitute 3–4% of primary
brain tumors, and in most cases are diffuse large B-cell
lymphomas (DLBCL).1 Low grade lymphomas as pri-
mary central nervous system (CNS) lymphoma are
very rare. We present here a case report of a woman
who presented with headache and was found to have
primary intracranial lymphoplasmacytic lymphoma
(LPL).CASE REPORT
A 53-year-old woman presented to emergency
department with a 3–4 month history of worsening
headaches on left side associated with occasional
blurriness of vision and tenderness to touch on left
side of her scalp. She denied photophobia, stiffnessof neck, fever, nausea or vomiting; there was no
variation in symptoms by position or movement.
One year prior, she had a cervical discectomy and fu-
sion of C3–C7. Her past medical history included
high blood pressure and dyslipidemia. She was a for-
mer smoker; her family history was non-contribu-
tory. Physical exam did not show any focal
neurologic signs, and strength in all the extremities
was normal. Non-contrast CT scan of head done
in the emergency department was normal. A contrast
enhanced MRI showed an extra-axial mass in the left
parietal region, with associated effacement of adja-
cent sulci, which demonstrated heterogeneous
enhancement following contrast administration with
associated effacement of adjacent sulci. It measured
3.9 · 1.1 cm in maximum transverse dimensions
and extended supero-inferiorly for approximately
3.5 cm. There was also an enhancing dural tail,
and the pattern was found to be most consistent
with meningioma. She was discharged with pain
medications and shortly thereafter was seen in neu-
rosurgery clinic.
Because of her persistent headaches and pain on
the left side of the head when she lay down, sheHematol Oncol Stem Cell Ther 6(2) Second Quarter 2013
Fig. 1. Lymphoplasmacytic lymphoma showing intranuclear inclusions.
LYMPHOPLASMACYTIC LYMPHOMA case reportunderwent a resection of the left parietal mass.
Pathology showed that the mass was generally com-
posed of small lymphoid cells with scattered plasma-
cytoid cells. Mature plasma cells were also noted.
Intranuclear inclusions (Russell bodies) were also
seen in some of the plasmacytoid cells (Fig. 1). This
pattern of lymphocytes and plasmacytoid cells with
Russell bodies was consistent with lymphoplasmacy-
tic lymphoma. Flow cytometry demonstrated mono-
clonal B cells that were negative for CD5 and CD10,
also consistent with this diagnosis. Her serum
immunoglobulin levels were IgG 1220 mg/dL, IgM
317 mg/dL and IgA 130 mg/dL. Her total protein
was 6.2 g/dL. Serum protein electrophoresis did
not show any distinct paraprotein but immunoﬁx-
ation showed abnormal monoclonal IgM and lambda
bands. Her beta microglobulin level was 1 mg/L,
LDH 131 IU/dL. Her hepatitis panel was positive
for hepatitis C antibody. A lumbar puncture was
done and cerebrospinal ﬂuid showed a total WBC
of 2/ll with 4% lymphocytes; cytology was negative
for malignant cells and no monoclonal bands were
seen on immunoﬁxation. Three weeks after this
diagnosis she was admitted with shortness of breath,
was found to have a pulmonary embolism, and was
started on enoxaparin. A PET CT scan was done
to look for other sites of lymphoma but this was
negative with no FDG avid lesions to show active
lymphoma. A bone marrow biopsy was performed
which showed no lymphoma involvement. Bone mar-
row was negative by ﬂow cytometry and cytogenetics
showed normal karyotype. Because of the localized
nature of the lymphoma and absence of either malig-
nant cells or monoclonal protein in the CSF, we
decided to treat with radiotherapy alone. She was
treated with a total dose of 5040 cGy in 40 fractionsHematol Oncol Stem Cell Ther 6(2) Second Quarter 2013to the tumor bed. After 1 year of follow up, there is
no evidence of disease recurrence.DISCUSSION
Lymphoplasmacytic lymphoma (LPL, previously
termed lymphoplasmacytoid lymphoma) is an uncom-
mon mature B-cell lymphoma usually involving the
bone marrow and, less commonly, the spleen and/or
lymph nodes.2
PCNSL is deﬁned as non-Hodgkin lymphoma
(NHL) arising within the CNS and conﬁned to it
at the time of diagnosis.3 Interestingly, the incidence
of PCNSL has been increasing at a rate higher than
peripheral non-Hodgkin lymphomas (NHL) or glial
tumors.4 PCNSL is characterized by a supratentorial
(and very rarely spinal) localization, intensive and
homogeneous contrast enhancement, minor or mod-
erate edema, absence of necrosis, and proximity to
the ventricles.5 Ninety-ﬁve percent of PCNSLs are
diffuse large B-cell lymphomas (DLBCL).6 Other
lymphoma categories like Burkitt’s, lymphoblastic,
marginal zone, and small lymphocytic lymphoma are
uncommon differential diagnoses. T-cell PCNSLs
are 2% of cases in Western countries.7
The largest case series of CNS low grade lympho-
mas reported 40 cases, which include eight T-cell lym-
phomas and 32 B-cell lymphomas. The low grade B-
cell lymphomas described in this series were predom-
inantly non-classiﬁable small lymphomas but 11 cases
of LPL and one case of follicular lymphoma were
noted.8 In another study of 15 patients with low grade
primary CNS lymphoma, only two were found to
have lymphoplasmacytic lymphoma.9 A study by Bog-
dahn et al in 1986 of 10 patients with primary CNS
low grade lymphomas had four patients with lympho-
plasmacytoid immunocytoma.10 Besides these case
series, we found four other cases of CNS lymphoplas-
macytic lymphoma in the literature.11–14 The conﬁr-
mation of the diagnosis and further speciﬁcation
may be difﬁcult in PCNSL due to the small amount
of biopsy material, which, however, is a general prob-
lem in brain tumors diagnosed by stereotactic biopsy.
The major diagnostic dilemma we had was to dif-
ferentiate primary CNS lymphoplasmacytic lym-
phoma from Bing–Neel syndrome. In a review by
Fintelmann et al. 15 the authors proposed to limit
the deﬁnition of Bing–Neel Syndrome to patients
with proven Waldenström’s macroglobulinemia and
CNS symptoms not due to hyperviscosity or large cell
transformation. But for diagnosis of Waldenström’s
macroglobulinemia, bone marrow involvement is a
major criterion. Because bone marrow biopsy was77
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negative in our patient, a diagnosis of primary CNS
lymphoplasmacytic lymphoma was made.
As low grade primary CNS lymphomas are very
rare, there are no set guidelines for treatment. Carrasco
et al reported a pituitary LPL patient who maintained
complete remission for 4 years after transsphenoidal
surgery, chemotherapy and radiotherapy.14 Braks
et al. (2000) reported a 42-year-old woman with a 3-
year history of headaches and vertigo and a 1-year his-
tory of seizures. The tumor, histologically an immuno-
cytoma, remained unchanged throughout the entire
observation period with anticonvulsive treatment
alone.11 Another study reported one patient with a
spinal cord LPL at T4 level. The patient received only
surgical resection (corpectomy) without neurologic se-quela and has lived without relapse for 51 months.9 In
the case of our patient, we decided to treat her only with
radiation.
We present here a very rare case of primary CNS
lymphoplasmacytic lymphoma. So far in the literature
only 21 cases have been reported. This case empha-
sizes that differentiating between a low grade CNS
B-cell lymphoma from a DLBCL or a reactive phe-
nomenon is essential, both from a therapeutic and a
prognostic standpoint.CONFLICT OF INTEREST
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